首页 > 最新文献

Journal of Breast Imaging最新文献

英文 中文
Effective Integration of Feedback in Breast Imaging: A "Guide for the Trainee". 乳腺成像反馈的有效整合:“培训生指南”。
IF 2 Q3 ONCOLOGY Pub Date : 2025-09-02 DOI: 10.1093/jbi/wbae095
Joshua A Greenstein, Martha Sevenich, Allison Aripoli

Receiving feedback can sometimes be difficult and uncomfortable but is an essential component of professional development in breast imaging. Trainees have an opportunity to leverage feedback in breast imaging by incorporating self-assessments, real-world patient outcomes, procedural feedback, patient interactions, and available audit data to build confidence and competency in residency and fellowship. We present strategies for seeking and receiving feedback with a growth mindset, including specific scenarios in breast imaging where trainees can incorporate feedback and maximize learning potential.

接受反馈有时会让人感到困难和不适,但却是乳腺成像专业发展的重要组成部分。学员有机会通过自我评估、真实世界的患者结果、手术反馈、患者互动以及可用的审计数据来利用乳腺成像中的反馈,从而在住院医师和研究员培训中建立信心和能力。我们介绍了以成长心态寻求和接受反馈的策略,包括乳腺成像中学员可以采纳反馈并最大限度发挥学习潜力的具体场景。
{"title":"Effective Integration of Feedback in Breast Imaging: A \"Guide for the Trainee\".","authors":"Joshua A Greenstein, Martha Sevenich, Allison Aripoli","doi":"10.1093/jbi/wbae095","DOIUrl":"10.1093/jbi/wbae095","url":null,"abstract":"<p><p>Receiving feedback can sometimes be difficult and uncomfortable but is an essential component of professional development in breast imaging. Trainees have an opportunity to leverage feedback in breast imaging by incorporating self-assessments, real-world patient outcomes, procedural feedback, patient interactions, and available audit data to build confidence and competency in residency and fellowship. We present strategies for seeking and receiving feedback with a growth mindset, including specific scenarios in breast imaging where trainees can incorporate feedback and maximize learning potential.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"483-491"},"PeriodicalIF":2.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143476979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unknown Case: 16-Year-Old Female Patient With a Newly Palpable Mass. 未知病例:16岁女性患者新可触及肿块。
IF 2 Q3 ONCOLOGY Pub Date : 2025-08-30 DOI: 10.1093/jbi/wbaf028
Abigail S Johnson, Amy M Fowler
{"title":"Unknown Case: 16-Year-Old Female Patient With a Newly Palpable Mass.","authors":"Abigail S Johnson, Amy M Fowler","doi":"10.1093/jbi/wbaf028","DOIUrl":"https://doi.org/10.1093/jbi/wbaf028","url":null,"abstract":"","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unknown Case: A 42-Year-Old Woman With Bilateral Palpable and Nonpalpable Breast Masses. 未知病例:42岁女性,双侧可触及及不可触及乳房肿块。
IF 2 Q3 ONCOLOGY Pub Date : 2025-08-30 DOI: 10.1093/jbi/wbaf020
Alex Tran, Xiaoqin Wang
{"title":"Unknown Case: A 42-Year-Old Woman With Bilateral Palpable and Nonpalpable Breast Masses.","authors":"Alex Tran, Xiaoqin Wang","doi":"10.1093/jbi/wbaf020","DOIUrl":"https://doi.org/10.1093/jbi/wbaf020","url":null,"abstract":"","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Percutaneous Drain Placement for Postsurgical Breast Region Fluid Collections. 经皮置管引流术治疗术后乳腺积液的安全性和有效性。
IF 2 Q3 ONCOLOGY Pub Date : 2025-05-17 DOI: 10.1093/jbi/wbae086
Sanna E Herwald, Wenhui Zhou, Debra Ikeda, Alexander Vezeridis

Objective: The purpose of this study was to describe the safety and efficacy of percutaneous drain placement for postoperative fluid collections in the breast.

Methods: A retrospective review was conducted of the patient characteristics, intervention data, and clinical outcomes of the 43 adult patients who underwent percutaneous drain placement for fluid collections at a tertiary care hospital over a 13-year period ending February 28, 2023.

Results: Most fluid collections treated with percutaneous drain placement were secondary to ipsilateral breast surgery (92%, 44/48), most commonly breast reduction (23%, 10/44) and mastectomy with immediate tissue expander reconstruction (16%, 7/44). Additional patients had fluid collections without prior ipsilateral breast surgery (8%, 4/48) and were excluded from further analysis. The fluid cultures from 39% of the cultured postsurgical fluid collections were positive (16/41), and Staphylococcus aureus was the most commonly cultured organism (15%, 6/41). The only immediate complication was the rupture of a tissue expander during drain placement in 1 patient. The median duration of percutaneous drainage for postsurgical fluid collections was 12 days (range: 1 to 49 days). Percutaneous drain placement achieved clinical success without any subsequent treatments in 73% (32/44) of patients. An additional 7% (3/44) of patients required subsequent image-guided aspiration procedures and/or percutaneous drain placements but avoided surgical treatment for a persistent fluid collection.

Conclusion: Postsurgical fluid collections after diverse breast surgeries represented the vast majority of the fluid collections referred to our academic practice for percutaneous drain placement. Percutaneous drain placement was a safe and effective treatment in this patient population.

目的:本研究的目的是描述经皮引流放置用于术后乳腺积液的安全性和有效性。方法:回顾性分析截至2023年2月28日的13年间,在某三级医院接受经皮引流置管收集液体的43例成年患者的患者特征、干预数据和临床结果。结果:经皮置管引流术治疗的大多数液体收集是继发于同侧乳房手术(92%,44/48),最常见的是乳房缩小(23%,10/44)和乳房切除术并立即组织扩张器重建(16%,7/44)。其他未做过同侧乳房手术的患者有积液(8%,4/48),并被排除在进一步分析之外。39%的术后液体培养阳性(16/41),金黄色葡萄球菌是最常见的培养菌(15%,6/41)。唯一的直接并发症是1例患者在放置引流管时组织扩张器破裂。经皮引流用于术后液体收集的中位持续时间为12天(范围:1至49天)。73%(32/44)的患者在没有任何后续治疗的情况下经皮引流取得了临床成功。另有7%(3/44)的患者需要随后的图像引导抽吸手术和/或经皮引流放置,但由于持续积液而避免手术治疗。结论:各种乳房手术后的术后积液占我们经皮引流术中积液的绝大部分。经皮置管是一种安全有效的治疗方法。
{"title":"Safety and Efficacy of Percutaneous Drain Placement for Postsurgical Breast Region Fluid Collections.","authors":"Sanna E Herwald, Wenhui Zhou, Debra Ikeda, Alexander Vezeridis","doi":"10.1093/jbi/wbae086","DOIUrl":"10.1093/jbi/wbae086","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to describe the safety and efficacy of percutaneous drain placement for postoperative fluid collections in the breast.</p><p><strong>Methods: </strong>A retrospective review was conducted of the patient characteristics, intervention data, and clinical outcomes of the 43 adult patients who underwent percutaneous drain placement for fluid collections at a tertiary care hospital over a 13-year period ending February 28, 2023.</p><p><strong>Results: </strong>Most fluid collections treated with percutaneous drain placement were secondary to ipsilateral breast surgery (92%, 44/48), most commonly breast reduction (23%, 10/44) and mastectomy with immediate tissue expander reconstruction (16%, 7/44). Additional patients had fluid collections without prior ipsilateral breast surgery (8%, 4/48) and were excluded from further analysis. The fluid cultures from 39% of the cultured postsurgical fluid collections were positive (16/41), and Staphylococcus aureus was the most commonly cultured organism (15%, 6/41). The only immediate complication was the rupture of a tissue expander during drain placement in 1 patient. The median duration of percutaneous drainage for postsurgical fluid collections was 12 days (range: 1 to 49 days). Percutaneous drain placement achieved clinical success without any subsequent treatments in 73% (32/44) of patients. An additional 7% (3/44) of patients required subsequent image-guided aspiration procedures and/or percutaneous drain placements but avoided surgical treatment for a persistent fluid collection.</p><p><strong>Conclusion: </strong>Postsurgical fluid collections after diverse breast surgeries represented the vast majority of the fluid collections referred to our academic practice for percutaneous drain placement. Percutaneous drain placement was a safe and effective treatment in this patient population.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"311-317"},"PeriodicalIF":2.0,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing Errors in Breast Imaging: Insights From Missed and Near-Missed Cases. 减少乳房成像的错误:从漏诊和差点漏诊病例的见解。
IF 2 Q3 ONCOLOGY Pub Date : 2025-05-17 DOI: 10.1093/jbi/wbaf005
Xiaoqin Wang, Braxton McFarland, Emily Xiao, Ryan Anderson, Laurie Fajardo

Errors and misdiagnosis in breast imaging are significant concerns for breast imaging radiologists due to the negative impacts on patients and the high legal risks. Using missed and nearly missed diagnoses of breast cancer cases, this article introduces radiologists to common factors contributing to errors and misdiagnosis in breast imaging, including radiologist errors, improper imaging techniques, lesion characteristics, and work environment challenges. The article also provides practical recommendations and potential strategies to reduce these errors focusing on actions applicable to individual radiologists. Understanding the common causes of diagnostic errors in breast imaging and implementing targeted mitigating strategies can help radiologists improve diagnostic precision, reduce malpractice risk, and enhance patient care.

由于对患者的负面影响和较高的法律风险,乳房成像中的错误和误诊是乳房成像放射科医师非常关注的问题。本文以乳腺癌漏诊和差点漏诊病例为例,向放射科医生介绍导致乳腺影像学错误和误诊的常见因素,包括放射科医生的失误、不恰当的影像学技术、病变特征和工作环境的挑战。文章还提供了实用的建议和潜在的策略,以减少这些错误的重点行动适用于个别放射科医生。了解乳腺成像诊断错误的常见原因并实施有针对性的缓解策略可以帮助放射科医生提高诊断精度,降低医疗事故风险,并加强患者护理。
{"title":"Reducing Errors in Breast Imaging: Insights From Missed and Near-Missed Cases.","authors":"Xiaoqin Wang, Braxton McFarland, Emily Xiao, Ryan Anderson, Laurie Fajardo","doi":"10.1093/jbi/wbaf005","DOIUrl":"10.1093/jbi/wbaf005","url":null,"abstract":"<p><p>Errors and misdiagnosis in breast imaging are significant concerns for breast imaging radiologists due to the negative impacts on patients and the high legal risks. Using missed and nearly missed diagnoses of breast cancer cases, this article introduces radiologists to common factors contributing to errors and misdiagnosis in breast imaging, including radiologist errors, improper imaging techniques, lesion characteristics, and work environment challenges. The article also provides practical recommendations and potential strategies to reduce these errors focusing on actions applicable to individual radiologists. Understanding the common causes of diagnostic errors in breast imaging and implementing targeted mitigating strategies can help radiologists improve diagnostic precision, reduce malpractice risk, and enhance patient care.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"363-377"},"PeriodicalIF":2.0,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sociodemographic Factors and Ethnic Disparities in Breast Density Awareness and Anxiety Among Women With Dense Breasts. 致密性乳房妇女的乳腺密度意识和焦虑的社会人口因素和种族差异。
IF 2 Q3 ONCOLOGY Pub Date : 2025-05-17 DOI: 10.1093/jbi/wbae090
Linda H Larsen, Katherine A Rosenberg, Taylor F Mahoney, Patrick H Walker, Mary Yamashita

Objective: To determine sociodemographic and clinical factors associated with breast density awareness and anxiety in women with dense breasts.

Methods: This cross-sectional retrospective study, from a breast cancer screening prospective case collection registry (NCT03257839), analyzed patient-reported awareness of their breast density and related anxiety with sociodemographic variables. Asymptomatic women aged ≥40 with heterogeneously or extremely dense breasts completed a prescreening questionnaire at 9 Mammography Quality Standards Act-certified centers spanning 8 states with and without breast density notification laws (BDNLs).

Results: Among 6873 women (mean age 54.6 ± 9.3 years) with 99.4% (6833/6873) questionnaire completion, 71.7% (4930/6873) of participants were aware of their breast density. Self-reported Hispanic/Latina women comprised 15.4% (1055/6873), of whom 75.5% (796/1055) had a state BDNL. Fewer Hispanic/Latina women with a BDNL in effect were aware of density than non-Hispanic/Latina women (50.7% [403/795] vs 83.9% [2416/2880], P <.001). In multivariable analyses, the adjusted odds ratio (AOR) of breast density awareness was higher in women with some college education (AOR 2.70 [95% CI, 2.36-3.08]), BDNL in effect (AOR 2.09 [95% CI, 1.86-2.34]), self-reported ethnicity of not Hispanic or Latina (AOR 1.68 [95% CI, 1.45-1.96]), and aged 70 to 79 years (AOR 1.73 [95% CI, 1.35-2.22]), 60 to 69 years (AOR 1.45 [95% CI, 1.25-1.69]), or 50 to 59 years (AOR 1.30 [95% CI, 1.15-1.48]) when compared with 40 to 49 years. Women with awareness were more likely to be anxious (AOR 1.98 [95% CI, 1.76-2.24]).

Conclusions: Despite overall density awareness in women with dense breasts and BDNL implementation, health care providers should address disparities of awareness and target discussions with women under 50, individuals with a Hispanic/Latina background, and those less educated.

目的:探讨与致密乳房患者乳腺密度认知和焦虑相关的社会人口学和临床因素。方法:这项横断面回顾性研究,来自乳腺癌筛查前瞻性病例收集登记(NCT03257839),分析患者报告的乳房密度意识和与社会人口统计学变量相关的焦虑。年龄≥40岁、乳房异质性或极度致密的无症状女性在8个有或没有乳房密度通知法(bdnl)的州的9个乳房x光检查质量标准法案认证的中心完成了一份预筛查问卷。结果:6873名女性(平均年龄54.6±9.3岁),问卷完成率为99.4%(6833/6873),其中71.7%(4930/6873)的参与者了解自己的乳腺密度。自我报告的西班牙裔/拉丁裔妇女占15.4%(1055/6873),其中75.5%(796/1055)有州BDNL。结论:尽管致密性乳房妇女的总体密度意识和BDNL的实施,但卫生保健提供者应解决意识的差异,并与50岁以下妇女、西班牙裔/拉丁裔背景的妇女和受教育程度较低的妇女进行目标讨论。
{"title":"Sociodemographic Factors and Ethnic Disparities in Breast Density Awareness and Anxiety Among Women With Dense Breasts.","authors":"Linda H Larsen, Katherine A Rosenberg, Taylor F Mahoney, Patrick H Walker, Mary Yamashita","doi":"10.1093/jbi/wbae090","DOIUrl":"https://doi.org/10.1093/jbi/wbae090","url":null,"abstract":"<p><strong>Objective: </strong>To determine sociodemographic and clinical factors associated with breast density awareness and anxiety in women with dense breasts.</p><p><strong>Methods: </strong>This cross-sectional retrospective study, from a breast cancer screening prospective case collection registry (NCT03257839), analyzed patient-reported awareness of their breast density and related anxiety with sociodemographic variables. Asymptomatic women aged ≥40 with heterogeneously or extremely dense breasts completed a prescreening questionnaire at 9 Mammography Quality Standards Act-certified centers spanning 8 states with and without breast density notification laws (BDNLs).</p><p><strong>Results: </strong>Among 6873 women (mean age 54.6 ± 9.3 years) with 99.4% (6833/6873) questionnaire completion, 71.7% (4930/6873) of participants were aware of their breast density. Self-reported Hispanic/Latina women comprised 15.4% (1055/6873), of whom 75.5% (796/1055) had a state BDNL. Fewer Hispanic/Latina women with a BDNL in effect were aware of density than non-Hispanic/Latina women (50.7% [403/795] vs 83.9% [2416/2880], P <.001). In multivariable analyses, the adjusted odds ratio (AOR) of breast density awareness was higher in women with some college education (AOR 2.70 [95% CI, 2.36-3.08]), BDNL in effect (AOR 2.09 [95% CI, 1.86-2.34]), self-reported ethnicity of not Hispanic or Latina (AOR 1.68 [95% CI, 1.45-1.96]), and aged 70 to 79 years (AOR 1.73 [95% CI, 1.35-2.22]), 60 to 69 years (AOR 1.45 [95% CI, 1.25-1.69]), or 50 to 59 years (AOR 1.30 [95% CI, 1.15-1.48]) when compared with 40 to 49 years. Women with awareness were more likely to be anxious (AOR 1.98 [95% CI, 1.76-2.24]).</p><p><strong>Conclusions: </strong>Despite overall density awareness in women with dense breasts and BDNL implementation, health care providers should address disparities of awareness and target discussions with women under 50, individuals with a Hispanic/Latina background, and those less educated.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":"7 3","pages":"318-330"},"PeriodicalIF":2.0,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a Career as a Clinician-Educator in Breast Imaging. 发展成为乳腺成像领域的临床教育工作者。
IF 2 Q3 ONCOLOGY Pub Date : 2025-05-17 DOI: 10.1093/jbi/wbae075
Alison Lynn Chetlen, Jeanine Beatty-Chadha, Angela I Choe

For the breast imaging radiologist, developing a career as a clinician-educator can be accomplished in a number of ways. Whether it be a new graduate or perhaps a radiologist making a midcareer or late-career pivot to the academic world, there are several opportunities and resources that can support a faculty member at any stage in this journey. In this article, the breast imaging radiologist will learn a variety of methods to strengthen their professional identity and career path as a clinician-educator through the early-, mid-, and late-career professional journey.

对于乳腺成像放射科医生来说,可以通过多种方式发展自己的临床教育事业。无论是刚毕业的学生,还是在职业生涯中期或晚期转向学术界的放射科医生,都有一些机会和资源可以在这一旅程的任何阶段为教职员工提供支持。在本文中,乳腺成像放射科医生将学习到各种方法,以加强他们作为临床教育工作者在职业生涯早期、中期和晚期的专业身份和职业道路。
{"title":"Developing a Career as a Clinician-Educator in Breast Imaging.","authors":"Alison Lynn Chetlen, Jeanine Beatty-Chadha, Angela I Choe","doi":"10.1093/jbi/wbae075","DOIUrl":"10.1093/jbi/wbae075","url":null,"abstract":"<p><p>For the breast imaging radiologist, developing a career as a clinician-educator can be accomplished in a number of ways. Whether it be a new graduate or perhaps a radiologist making a midcareer or late-career pivot to the academic world, there are several opportunities and resources that can support a faculty member at any stage in this journey. In this article, the breast imaging radiologist will learn a variety of methods to strengthen their professional identity and career path as a clinician-educator through the early-, mid-, and late-career professional journey.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"355-362"},"PeriodicalIF":2.0,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contrast-Enhanced Mammography Implementation: Early Struggles and Successes. 对比增强乳房x光检查的实施:早期的挣扎和成功。
IF 2 Q3 ONCOLOGY Pub Date : 2025-05-17 DOI: 10.1093/jbi/wbaf018
Brittany Z Dashevsky, Laura J Fish, Shelby Breit, Uzma Waheed, Kristen Coffey, Jay R Parikh, Lisa A Mullen, Beatriu Reig, Brian N Dontchos, Katerina Dodelzon, Lars J Grimm

We used focus groups of radiologists who led the implementation of contrast-enhanced mammography (CEM) in their practice to identify barriers and strategies for adoption. Members of the Society of Breast Imaging in the United States who served as lead on CEM implementation were invited to participate in 2 separate focus groups. Ten breast imaging radiologists with varied geographic and practice type (60% academic, 30% private, and 10% community practice) participated. There were 4 major themes identified: patient selection, workflow, contrast, and billing. Patient selection varied widely among practices, with some limiting CEM to patients unable to obtain MRI and others routinely using CEM for diagnostic workup. Lack of Food and Drug Administration approval limited screening applications in some practices. Workflow challenges were numerous, and site-specific solutions were developed for ordering, scheduling, staffing, and intravenous access. There were universal concerns regarding contrast, including safe administration, response to reactions, and biopsy planning for findings only visible on CEM. Contrast reaction training, including conducting mock codes at some practices, helped alleviate concerns of the radiologists and technologists. Finally, billing was an administrative hurdle that influenced patient selection. Ample preparation is needed to successfully start a CEM program with particular attention to patient selection, workflow, contrast administration/reactions, and billing.

我们使用了在实践中领导实施对比增强乳房x线照相术(CEM)的放射科医生的焦点小组来确定采用该技术的障碍和策略。美国乳腺成像学会的成员作为CEM实施的领导者被邀请参加两个独立的焦点小组。10名不同地域和执业类型的乳腺成像放射科医生(60%为学术,30%为私人执业,10%为社区执业)参与了研究。确定了4个主要主题:患者选择、工作流程、对比和计费。患者选择在实践中差异很大,一些限制CEM患者无法获得MRI和其他常规使用CEM诊断工作。缺乏食品和药物管理局的批准在某些实践中限制了筛选的应用。工作流程的挑战是众多的,并且针对订货、调度、人员配置和静脉注射访问开发了特定于站点的解决方案。人们普遍关注造影剂,包括安全给药,对反应的反应,以及仅在CEM上可见的活检计划。对比反应训练,包括在一些实践中进行模拟代码,有助于减轻放射科医生和技术人员的担忧。最后,账单是一个影响患者选择的行政障碍。成功启动CEM项目需要充分的准备,特别注意患者选择、工作流程、对比管理/反应和计费。
{"title":"Contrast-Enhanced Mammography Implementation: Early Struggles and Successes.","authors":"Brittany Z Dashevsky, Laura J Fish, Shelby Breit, Uzma Waheed, Kristen Coffey, Jay R Parikh, Lisa A Mullen, Beatriu Reig, Brian N Dontchos, Katerina Dodelzon, Lars J Grimm","doi":"10.1093/jbi/wbaf018","DOIUrl":"https://doi.org/10.1093/jbi/wbaf018","url":null,"abstract":"<p><p>We used focus groups of radiologists who led the implementation of contrast-enhanced mammography (CEM) in their practice to identify barriers and strategies for adoption. Members of the Society of Breast Imaging in the United States who served as lead on CEM implementation were invited to participate in 2 separate focus groups. Ten breast imaging radiologists with varied geographic and practice type (60% academic, 30% private, and 10% community practice) participated. There were 4 major themes identified: patient selection, workflow, contrast, and billing. Patient selection varied widely among practices, with some limiting CEM to patients unable to obtain MRI and others routinely using CEM for diagnostic workup. Lack of Food and Drug Administration approval limited screening applications in some practices. Workflow challenges were numerous, and site-specific solutions were developed for ordering, scheduling, staffing, and intravenous access. There were universal concerns regarding contrast, including safe administration, response to reactions, and biopsy planning for findings only visible on CEM. Contrast reaction training, including conducting mock codes at some practices, helped alleviate concerns of the radiologists and technologists. Finally, billing was an administrative hurdle that influenced patient selection. Ample preparation is needed to successfully start a CEM program with particular attention to patient selection, workflow, contrast administration/reactions, and billing.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":"7 3","pages":"345-354"},"PeriodicalIF":2.0,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peri-Implant Enhancement of the Breast: Imaging Features, Significance, and Management Strategies. 乳房植入体周围增强:影像特征、意义和管理策略。
IF 2 Q3 ONCOLOGY Pub Date : 2025-05-17 DOI: 10.1093/jbi/wbae084
Santo Maimone, Shweta Srivastava, Olivia S Ho, Kristin A Robinson, Andrey P Morozov, Haley P Letter, Amie Leon, Brian D Rinker

Objective: Peri-implant enhancement can be seen on contrast-enhanced breast MRI, but its association with malignancy has not been described, leading to considerable variability in assessment and recommendations by radiologists. This study evaluated imaging features, management, and outcomes of implant-related enhancement.

Methods: This multisite IRB-approved retrospective review queried all breast MRI reports for keywords describing peri-implant enhancement, fluid, and/or masses (plus synonymous descriptions) and implant-associated malignancies, with subsequent imaging and chart review. Peri-implant enhancement and implant features were characterized. Assessments and outcomes were evaluated via clinical and imaging follow-up, aspiration/biopsy, and/or capsulectomy to evaluate for association of peri-implant enhancement with implant-related malignancy.

Results: A total of 100 patients had peri-implant enhancement. Uniform thin peripheral enhancement was most common (79/100, 79%). Capsulectomy was performed in 31/100 (31%), with benign capsular fibrosis/inflammation discovered in 26/31 (83.9%). Breast implant-associated anaplastic large cell lymphoma was present in 2/100 (2%), both with textured implants, while 98/100 (98%) had no implant-related malignancy. MRI recommendations varied: resume routine imaging (26/100, 26%), clinical management (18/100, 18%), follow-up MRI (17/100, 17%), MRI-directed US (17/100, 17%), aspiration/biopsy (11/100, 11%), and surgical consultation (10/100, 10%).

Conclusion: Peri-implant enhancement is a nonspecific imaging finding with a low malignant association, especially when seen in isolation (no associated effusion, mass, or adenopathy). Implant surface texture should be considered in management recommendations; diagnostic capsulectomy is not recommended in patients with smooth implants. Additional studies are encouraged to validate nonoperative management recommendations.

目的:乳房MRI造影剂增强可以看到植入物周围增强,但其与恶性肿瘤的关联尚未被描述,导致放射科医生在评估和建议方面存在相当大的差异。本研究评估了植入物相关增强的影像学特征、处理和结果。方法:这项多位点irb批准的回顾性研究查询了所有描述植入物周围增强、液体和/或肿块(加上同义描述)和植入物相关恶性肿瘤的乳房MRI报告,并进行了随后的成像和图表回顾。描述了种植体周围增强和种植体特征。评估和结果通过临床和影像学随访、抽吸/活检和/或荚膜切除术来评估种植体周围增强与种植体相关恶性肿瘤的关系。结果:100例患者均有种植体周围增强。均匀薄周增强最为常见(79/100,79%)。31/100(31%)患者行囊切除术,26/31(83.9%)患者发现良性囊纤维化/炎症。乳房植入物相关间变性大细胞淋巴瘤2/100(2%)存在,都是有纹理的植入物,而98/100(98%)没有植入物相关的恶性肿瘤。MRI的建议各不相同:恢复常规影像学(26/ 100,26%),临床管理(18/ 100,18%),随访MRI (17/ 100,17%), MRI指导下的US(17/ 100,17%),抽吸/活检(11/ 100,11%)和手术咨询(10/ 100,10%)。结论:种植体周围增强是一种低恶性关联的非特异性影像学发现,尤其是在单独观察时(无相关积液、肿块或腺病)。在管理建议中应考虑种植体表面纹理;诊断性荚膜切除术不推荐用于光滑种植体的患者。鼓励更多的研究来验证非手术治疗建议。
{"title":"Peri-Implant Enhancement of the Breast: Imaging Features, Significance, and Management Strategies.","authors":"Santo Maimone, Shweta Srivastava, Olivia S Ho, Kristin A Robinson, Andrey P Morozov, Haley P Letter, Amie Leon, Brian D Rinker","doi":"10.1093/jbi/wbae084","DOIUrl":"10.1093/jbi/wbae084","url":null,"abstract":"<p><strong>Objective: </strong>Peri-implant enhancement can be seen on contrast-enhanced breast MRI, but its association with malignancy has not been described, leading to considerable variability in assessment and recommendations by radiologists. This study evaluated imaging features, management, and outcomes of implant-related enhancement.</p><p><strong>Methods: </strong>This multisite IRB-approved retrospective review queried all breast MRI reports for keywords describing peri-implant enhancement, fluid, and/or masses (plus synonymous descriptions) and implant-associated malignancies, with subsequent imaging and chart review. Peri-implant enhancement and implant features were characterized. Assessments and outcomes were evaluated via clinical and imaging follow-up, aspiration/biopsy, and/or capsulectomy to evaluate for association of peri-implant enhancement with implant-related malignancy.</p><p><strong>Results: </strong>A total of 100 patients had peri-implant enhancement. Uniform thin peripheral enhancement was most common (79/100, 79%). Capsulectomy was performed in 31/100 (31%), with benign capsular fibrosis/inflammation discovered in 26/31 (83.9%). Breast implant-associated anaplastic large cell lymphoma was present in 2/100 (2%), both with textured implants, while 98/100 (98%) had no implant-related malignancy. MRI recommendations varied: resume routine imaging (26/100, 26%), clinical management (18/100, 18%), follow-up MRI (17/100, 17%), MRI-directed US (17/100, 17%), aspiration/biopsy (11/100, 11%), and surgical consultation (10/100, 10%).</p><p><strong>Conclusion: </strong>Peri-implant enhancement is a nonspecific imaging finding with a low malignant association, especially when seen in isolation (no associated effusion, mass, or adenopathy). Implant surface texture should be considered in management recommendations; diagnostic capsulectomy is not recommended in patients with smooth implants. Additional studies are encouraged to validate nonoperative management recommendations.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"301-310"},"PeriodicalIF":2.0,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142872983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing Screening Outcomes: A Guide for Breast Imaging Practices. 优化筛查结果:乳腺成像实践指南。
IF 2 Q3 ONCOLOGY Pub Date : 2025-05-17 DOI: 10.1093/jbi/wbae093
Sora C Yoon, Jay A Baker, Lars J Grimm

Radiologists face a range of challenges to maximize the life-saving benefits of screening mammography, including pressure to maintain accuracy, manage heavy workloads, and minimize the risk of fatigue and burnout. This review provides targeted strategies to address these challenges and, ultimately, to improve interpretive performance of screening mammography. Workflow optimizations, including offline vs online and batched vs nonbatched interpretation, interrupted vs uninterrupted reading, and the importance of comparing current mammograms with prior examinations will be explored. Each strategy has strengths, weaknesses, and logistical challenges that must be tailored to the individual practice environment. Moreover, as breast radiologists contend with increasingly busy and hectic working conditions, practical solutions to protect reading environments and minimize distractions, such as the "sterile cockpit" approach, will be described. Additionally, breast radiologists are at greater risk for fatigue and burnout due to rising clinic volumes and an inadequate workforce. Optimizing the approach to reading screens is critical to helping breast imaging radiologists maintain and maximize the benefits of screening mammography, ensure the best outcomes for our patients, and maintain radiologist job satisfaction.

放射科医生面临着一系列的挑战,以最大限度地提高筛查乳房x光检查的挽救生命的好处,包括保持准确性的压力,管理繁重的工作量,并尽量减少疲劳和倦怠的风险。这篇综述提供了有针对性的策略来解决这些挑战,并最终提高乳房x光筛查的解释性能。工作流程优化,包括离线与在线、批量与非批量解释、中断与不间断阅读,以及将当前乳房x光片与先前检查进行比较的重要性将被探讨。每种策略都有优点、缺点和后勤挑战,必须根据个人实践环境进行调整。此外,随着乳腺放射科医生应对日益繁忙和紧张的工作条件,保护阅读环境和尽量减少干扰的实用解决方案,如“无菌驾驶舱”方法,将被描述。此外,由于诊所数量的增加和劳动力的不足,乳腺放射科医生面临着更大的疲劳和倦怠风险。优化阅读屏幕的方法对于帮助乳腺成像放射科医生保持和最大化筛查乳房x光检查的好处,确保我们的患者获得最佳结果,并保持放射科医生的工作满意度至关重要。
{"title":"Optimizing Screening Outcomes: A Guide for Breast Imaging Practices.","authors":"Sora C Yoon, Jay A Baker, Lars J Grimm","doi":"10.1093/jbi/wbae093","DOIUrl":"10.1093/jbi/wbae093","url":null,"abstract":"<p><p>Radiologists face a range of challenges to maximize the life-saving benefits of screening mammography, including pressure to maintain accuracy, manage heavy workloads, and minimize the risk of fatigue and burnout. This review provides targeted strategies to address these challenges and, ultimately, to improve interpretive performance of screening mammography. Workflow optimizations, including offline vs online and batched vs nonbatched interpretation, interrupted vs uninterrupted reading, and the importance of comparing current mammograms with prior examinations will be explored. Each strategy has strengths, weaknesses, and logistical challenges that must be tailored to the individual practice environment. Moreover, as breast radiologists contend with increasingly busy and hectic working conditions, practical solutions to protect reading environments and minimize distractions, such as the \"sterile cockpit\" approach, will be described. Additionally, breast radiologists are at greater risk for fatigue and burnout due to rising clinic volumes and an inadequate workforce. Optimizing the approach to reading screens is critical to helping breast imaging radiologists maintain and maximize the benefits of screening mammography, ensure the best outcomes for our patients, and maintain radiologist job satisfaction.</p>","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"259-267"},"PeriodicalIF":2.0,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Breast Imaging
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1